Literature DB >> 27519476

The roles of the Hippo pathway in cancer metastasis.

Helena J Janse van Rensburg1, Xiaolong Yang2.   

Abstract

Cancer metastasis refers to the sequence of events whereby tumour cells detach from their primary tissue, invade and migrate to nearby vasculature, intravasate into circulation, survive in circulation and extravasate at a distant site to establish a secondary tumour. Each step in this "metastatic cascade" is coordinated by complex molecular events that remain only incompletely understood. Given that the vast majority of cancer fatalities occur due to metastasis, there is an urgent need for an improved understanding of the specific mechanisms underlying cancer metastasis and for the development of therapeutics targeting this lethal process. The Hippo pathway is an emerging signaling pathway that plays important roles in development and disease. In cancer cells, dysregulation of the Hippo pathway drives multiple aspects of tumour initiation and progression. Recent studies have uncovered a role for the Hippo pathway core components in promoting cancer metastasis. In this review, we summarize the clinical and biochemical evidence implicating the Hippo pathway in metastasis. Additionally, we describe the molecular mechanisms by which aberrant Hippo signaling promotes metastasis. Finally, we highlight areas for future research.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cell migration; EMT; Hippo pathway; Metastasis; Tumour suppressor

Mesh:

Substances:

Year:  2016        PMID: 27519476     DOI: 10.1016/j.cellsig.2016.08.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  40 in total

1.  A Ca2+-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Authors:  Donna K Dang; Monish Ram Makena; José P Llongueras; Hari Prasad; Myungjun Ko; Manuj Bandral; Rajini Rao
Journal:  Mol Cancer Res       Date:  2019-05-10       Impact factor: 5.852

Review 2.  A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression.

Authors:  Hong-Li Li; Qian-Yu Li; Min-Jie Jin; Chao-Fan Lu; Zhao-Yang Mu; Wei-Yi Xu; Jian Song; Yan Zhang; Sai-Yang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-17       Impact factor: 4.553

3.  A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.

Authors:  Kazem Nouri; Taha Azad; Elizabeth Lightbody; Prem Khanal; Christopher J Nicol; Xiaolong Yang
Journal:  FASEB J       Date:  2019-08-20       Impact factor: 5.191

4.  YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.

Authors:  Yi-Zih Kuo; Ya-Rong Kang; Wei-Lun Chang; Lydia Chin-Ling Sim; Tzu-Chin Hsieh; Chu-Han Chang; Yi-Ching Wang; Ching-Jung Tsai; Li-Chun Huang; Sen-Tien Tsai; Li-Wha Wu
Journal:  Cell Oncol (Dordr)       Date:  2022-08-05       Impact factor: 7.051

Review 5.  The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.

Authors:  Ioanna Akrida; Vasiliki Bravou; Helen Papadaki
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

6.  Smoke-induced SAV1 Gene Promoter Hypermethylation Disrupts YAP Negative Feedback and Promotes Malignant Progression of Non-small Cell Lung Cancer.

Authors:  Ting Liu; Wei Guo; Kai Luo; Lei Li; Jing Dong; Meijun Liu; Xingyuan Shi; Zhiyuan Wang; Jianlei Zhang; Jiang Yin; Ni Qiu; Minying Lu; Danyang Chen; Xiaoting Jia; Hao Liu; Yixue Gu; Yan Xiong; Guopei Zheng; Gang Xu; Zhimin He; Zhijie Zhang
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

7.  Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor.

Authors:  Taha Azad; Kazem Nouri; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

8.  Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.

Authors:  Xiaoting Jiang; Zhengchuang Liu; Yingjie Xia; Jungang Luo; Ji Xu; Xujun He; Houquan Tao
Journal:  Oncotarget       Date:  2017-12-26

9.  A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.

Authors:  T Azad; H J Janse van Rensburg; E D Lightbody; B Neveu; A Champagne; A Ghaffari; V R Kay; Y Hao; H Shen; B Yeung; B A Croy; K L Guan; F Pouliot; J Zhang; C J B Nicol; X Yang
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

10.  Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.

Authors:  Jing Zhang; Hui Liu; Lidan Hou; Ge Wang; Rui Zhang; Yanxia Huang; Xiaoyu Chen; Jinshui Zhu
Journal:  Mol Cancer       Date:  2017-09-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.